Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
BACKGROUND/AIMS: This study was designed to determine whether previous Cushing's disease (CD) or prolactinoma (PRL) could exert adverse effects additional to those of growth hormone (GH) deficiency as a consequence of variable degrees of prior hypogonadism or hypercatabolism. We report the effe...
Hlavní autoři: | Colson, A, Brooke, A, Walker, D, Besser, G, Chew, S, Grossman, AB, Jenkins, P, Drake, WM, Monson, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2006
|
Podobné jednotky
-
Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
Autor: Colson, A, a další
Vydáno: (2008) -
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Autor: Bonert Vivien S, a další
Vydáno: (2010-05-01) -
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Autor: Chung, T, a další
Vydáno: (2008) -
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Autor: Chung, T, a další
Vydáno: (2005) -
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Autor: Korbonits, M, a další
Vydáno: (1998)